SeaSpine to Present at the Canaccord Genuity 42nd Annual Global Growth Conference
SeaSpine Holdings Corporation (NASDAQ: SPNE) announced its participation in the Canaccord Genuity 42nd Annual Global Growth Conference scheduled for August 10, 2022, starting at 8:00 AM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
SeaSpine Holdings Corporation (NASDAQ: SPNE) announced its participation in the Canaccord Genuity 42nd Annual Global Growth Conference scheduled for August 10, 2022, starting at 8:00 AM ET. The event aims to showcase the company's innovative surgical solutions for spinal disorders, including its FLASH™ Navigation system, which enhances surgical accuracy. A live and archived webcast will be accessible on SeaSpine's website. The company specializes in advanced spinal implants and orthobiologics, serving markets in the U.S. and approximately 30 countries.
Details
News Market Reaction – SPNE
The recorded move for SPNE in the trading session of this news was +1.18%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will present at the Canaccord Genuity 42nd Annual Global Growth Conference on August 10, 2022 beginning at 8:00 AM ET.
A live and archived webcast of the event will be available from the Investors section of the SeaSpine website at: www.seaspine.com.
About SeaSpine
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine’s complete procedural solutions feature its market-leading FLASH™ Navigation, a system designed to improve accuracy of screw placement and provide a cost-effective, rapid, radiation-free solution to surgical navigation, and a comprehensive portfolio of spinal implants and orthobiologics to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures on the lumbar, thoracic and cervical spine. With product development expertise in advanced optics, software, orthobiologic sciences and spinal implants, SeaSpine can offer its surgeon customers a complete solution to meet their patients’ evolving clinical needs. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.
Investor Relations Contact
Leigh Salvo
ir@seaspine.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.